1887

Abstract

Live attenuated strains of human cytomegalovirus are under development as vaccines to prevent birth defects resulting from congenital infections. These strains encode four proteins that inhibit surface expression of MHC class I, presumably to evade cytotoxic T-cell recognition and, perhaps, attenuate induction of immunity. To initiate studies of the role of class I down-regulation on congenital infection and vaccine efficacy, the ability of guinea pig cytomegalovirus to down-regulate class I was examined. Surface class I was specifically down-regulated on infected cells up to 8-fold. Sensitivity to UV irradiation and insensitivity to a viral DNA synthesis inhibitor revealed that immediate early or early viral gene(s) are responsible. Identification of these genes will permit future experiments to evaluate the role of class I down-regulation in congenital cytomegalovirus disease and its impact on vaccine efficacy. These findings should be pertinent to understanding human cytomegalovirus disease and may help guide the design of candidate vaccines.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.18675-0
2003-01-01
2020-12-01
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/1/vir840075.html?itemId=/content/journal/jgv/10.1099/vir.0.18675-0&mimeType=html&fmt=ahah

References

  1. Abbate J., Lacayo J. C., Prichard M., Pari G., McVoy M. A.. 2001; Bifunctional protein conferring enhanced green fluorescence and puromycin resistance. Biotechniques31:336–340
    [Google Scholar]
  2. Abendroth A., Lin I., Slobedman B., Ploegh H., Arvin A. M.. 2001; Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J Virol75:4878–4888
    [Google Scholar]
  3. Ahn K., Angulo A., Ghazal P., Peterson P. A., Yang Y., Fruh K.. 1996; Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci U S A93:10990–10995
    [Google Scholar]
  4. Ahn K., Gruhler A., Galocha B., Jones T. R., Wiertz E. J., Ploegh H. L., Peterson P. A., Yang Y., Fruh K.. 1997; The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity6:613–621
    [Google Scholar]
  5. Ambagala A. P., Hinkley S., Srikumaran S.. 2000; An early pseudorabies virus protein down-regulates porcine MHC class I expression by inhibition of transporter associated with antigen processing (TAP). J Immunol164:93–99
    [Google Scholar]
  6. Balfour H. H., Jr Sachs G. W., Welo P., Gehrz R. C., Simmons R. L., Najarian J. S.. 1984; Cytomegalovirus vaccine in renal transplant candidates: progress report of a randomized, placebo-controlled, double-blind trial. Birth Defects Orig Artic Ser20:289–304
    [Google Scholar]
  7. Barnes P. D., Grundy J. E.. 1992; Down-regulation of the class I HLA heterodimer and β2-microglobulin on the surface of cells infected with cytomegalovirus. J Gen Virol73:2395–2403
    [Google Scholar]
  8. Bia F. J., Griffith B. P., Tarsio M., Hsiung G. D.. 1980; Vaccination for the prevention of maternal and fetal infection with guinea pig cytomegalovirus. J Infect Dis142:732–738
    [Google Scholar]
  9. Bia F. J., Lucia H. L., Fong C. K., Tarsio M., Hsiung G. D.. 1982; Effects of vaccination on cytomegalovirus-associated interstitial pneumonia in strain 2 guinea pigs. J Infect Dis145:742–747
    [Google Scholar]
  10. Campbell A. E., Slater J. S.. 1994; Down-regulation of major histocompatibility complex class I synthesis by murine cytomegalovirus early gene expression. J Virol68:1805–1811
    [Google Scholar]
  11. Cohen J. I.. 1998; Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens. J Infect Dis177:1390–1393
    [Google Scholar]
  12. del Val M., Hengel H., Hacker H., Hartlaub U., Ruppert T., Lucin P., Koszinowski U. H.. 1992; Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J Exp Med176:729–738
    [Google Scholar]
  13. Fong C. K., Lucia H., Bia F. J., Hsiung G. D.. 1983; Histopathologic and ultrastructural studies of disseminated cytomegalovirus infection in strain 2 guinea pigs. Lab Invest49:183–194
    [Google Scholar]
  14. Fortunato E. A., Dell’Aquila M. L., Spector D. H.. 2000; Specific chromosome 1 breaks induced by human cytomegalovirus. Proc Nat Acad Sci U S A97:853–858
    [Google Scholar]
  15. Fowler K. B., Stagno S., Pass R. F., Britt W. J., Boll T. J., Alford C. A.. 1992; The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med326:663–667
    [Google Scholar]
  16. Gonczol E., Plotkin S.. 2001; Development of a cytomegalovirus vaccine: lessons from recent clinical trials. Expert Opin Biol Ther1:401–412
    [Google Scholar]
  17. Griffith B. P., Aquino-de Jesus M. J.. 1991; Guinea pig model of congenital cytomegalovirus infection. Transplant Proc23:29–31
    [Google Scholar]
  18. Griffith B. P., Lucia H. L., Bia F. J., Hsiung G. D.. 1981; Cytomegalovirus-induced mononucleosis in guinea pigs. Infect Immun32:857–863
    [Google Scholar]
  19. Griffith B. P., Chen M., Isom H. C.. 1990; Role of primary and secondary maternal viremia in transplacental guinea pig cytomegalovirus transfer. J Virol64:1991–1997
    [Google Scholar]
  20. Hallermalm K., Seki K., Wei C., Castelli C., Rivoltini L., Kiessling R., Levitskaya J.. 2001; Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface. Blood98:1108–1115
    [Google Scholar]
  21. Hariharan M. J., Nataraj C., Srikumaran S.. 1993; Down regulation of murine MHC class I expression by bovine herpesvirus 1. Viral Immunol6:273–284
    [Google Scholar]
  22. Harrison C. J., Britt W. J., Chapman N. M., Mullican J., Tracy S.. 1995; Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary CMV infection in the guinea pig model. J Infect Dis172:1212–1220
    [Google Scholar]
  23. Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., Ploegh H., Johnson D.. 1995; Herpes simplex virus turns off the TAP to evade host immunity. Nature375:411–415
    [Google Scholar]
  24. Hinkley S., Hill A. B., Srikumaran S.. 1998; Bovine herpesvirus-1 infection affects the peptide transport activity in bovine cells. Virus Res53:91–96
    [Google Scholar]
  25. Hirata Y., Kondo K., Yamanishi K.. 2001; Human herpesvirus 6 downregulates major histocompatibility complex class I in dendritic cells. J Med Virol65:576–583
    [Google Scholar]
  26. Hudson A. W., Howley P. M., Ploegh H. L.. 2001; A human herpesvirus 7 glycoprotein, U21, diverts major histocompatibility complex class I molecules to lysosomes. J Virol75:12347–12358
    [Google Scholar]
  27. Hunt H. D., Lupiani B., Miller M. M., Gimeno I., Lee L. F., Parcells M. S.. 2001; Marek's disease virus down-regulates surface expression of MHC (B Complex) class I (BF) glycoproteins during active but not latent infection of chicken cells. Virology282:198–205
    [Google Scholar]
  28. Ishido S., Wang C., Lee B. S., Cohen G. B., Jung J. U.. 2000; Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol74:5300–5309
    [Google Scholar]
  29. Jing X. J., Kalman-Maltese V., Cao X., Yang Q., Trempe J. P.. 2001; Inhibition of adenovirus cytotoxicity, replication, and E2a gene expression by adeno-associated virus. Virology291:140–151
    [Google Scholar]
  30. Johnson K. P., Connor W. S.. 1979; Guinea pig cytomegalovirus: transplacental transmission. Brief report. Arch Virol59:263–267
    [Google Scholar]
  31. Jones T. R., Sun L.. 1997; Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J Virol71:2970–2979
    [Google Scholar]
  32. Jones T. R., Hanson L. K., Sun L., Slater J. S., Stenberg R. M., Campbell A. E.. 1995; Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J Virol69:4830–4841
    [Google Scholar]
  33. Jones T. R., Wiertz E. J., Sun L., Fish K. N., Nelson J. A., Ploegh H. L.. 1996; Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A93:11327–11333
    [Google Scholar]
  34. Jugovic P., Hill A. M., Tomazin R., Ploegh H., Johnson D. C.. 1998; Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47. J Virol72:5076–5084
    [Google Scholar]
  35. Kemble G., Duke G., Winter R., Spaete R.. 1996; Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids. J Virol70:2044–2048
    [Google Scholar]
  36. Ledbetter J. A., Herzenberg L. A.. 1979; Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev47:63–90
    [Google Scholar]
  37. Liu Y., Biegalke B. J.. 2001; Characterization of a cluster of late genes of guinea pig cytomegalovirus. Virus Genes23:247–256
    [Google Scholar]
  38. Lorenzo M. E., Ploegh H. L., Tirabassi R. S.. 2001; Viral immune evasion strategies and the underlying cell biology. Semin Immunol13:1–9
    [Google Scholar]
  39. McVoy M. A., Nixon D. E., Adler S. P.. 1997; Circularization and cleavage of guinea pig cytomegalovirus genomes. J Virol71:4209–4217
    [Google Scholar]
  40. Nankervis G. A., Kumar M. L.. 1978; Diseases produced by cytomegaloviruses. Med Clin North Am62:1021–1035
    [Google Scholar]
  41. Nataraj C., Eidmann S., Hariharan M. J., Sur J. H., Perry G. A., Srikumaran S.. 1997; Bovine herpesvirus 1 downregulates the expression of bovine MHC class I molecules. Viral Immunol10:21–34
    [Google Scholar]
  42. Plotkin S. A., Starr S. E., Friedman H. M.. 7 other authors 1991; Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. Ann Intern Med114:525–531
    [Google Scholar]
  43. Plotkin S. A., Higgins R., Kurtz J. B., Morris P. J., Campbell D. A. Jr, Shope T. C., Spector S. A., Dankner W. M.. 1994; Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients. Transplantation58:1176–1178
    [Google Scholar]
  44. Rescigno M., Citterio S., Thery C., Rittig M., Medaglini D., Pozzi G., Amigorena S., Ricciardi-Castagnoli P.. 1998; Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc Natl Acad Sci U S A95:5229–5234
    [Google Scholar]
  45. Reusch U., Muranyi W., Lucin P., Burgert H. G., Hengel H., Koszinowski U. H.. 1999; A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J18:1081–1091
    [Google Scholar]
  46. Sambrook J., Fritsch E. F., Maniatis T.. 1989; Molecular Cloning, a Laboratory Manual , 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  47. Sato H., Inaba T., Kamiya H.. 1997; Production of murine monoclonal antibodies to guinea pig leukocytes and immunohistochemistry of guinea pig skin exposed to Schistosoma mansoni . Hybridoma16529–536
    [Google Scholar]
  48. Schäfer H., Bartels T., Hahn G., Otto A., Burger R.. 1999; T-cell-activating monoclonal antibodies, reacting with both leukocytes and erythrocytes, recognize the guinea pig Thy-1 differentiation antigen: characterization and cloning of guinea pig CD90. Cell Immunol197:116–128
    [Google Scholar]
  49. Schleiss M. R., Bourne N., Jensen N. J., Bravo F., Bernstein D. I.. 2000; Immunogenicity evaluation of DNA vaccines that target guinea pig cytomegalovirus proteins glycoprotein B and UL83. Viral Immunol13:155–167
    [Google Scholar]
  50. Steinmassl M., Hamprecht K.. 1994; Double fluorescence analysis of human cytomegalovirus (HCMV) infected human fibroblast cultures by flow cytometry: increase of class I MHC expression on uninfected cells and decrease on infected cells. Arch Virol135:75–87
    [Google Scholar]
  51. Stevenson P. G., Efstathiou S., Doherty P. C., Lehner P. J.. 2000; Inhibition of MHC class I-restricted antigen presentation by γ2-herpesviruses. Proc Natl Acad Sci U S A97:8455–8460
    [Google Scholar]
  52. Tomazin R., van Schoot N. E., Goldsmith K., Jugovic P., Sempe P., Fruh K., Johnson D. C.. 1998; Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J Virol72:2560–2563
    [Google Scholar]
  53. Wiertz E. J., Jones T. R., Sun L., Bogyo M., Geuze H. J., Ploegh H. L.. 1996; The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell84:769–779
    [Google Scholar]
  54. Yamashita Y., Shimokata K., Mizuno S., Yamaguchi H., Nishiyama Y.. 1993; Down-regulation of the surface expression of class I MHC antigens by human cytomegalovirus. Virol193:727–736
    [Google Scholar]
  55. York I. A., Roop C., Andrews D. W., Riddell S. R., Graham F. L., Johnson D. C.. 1994; A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell77:525–535
    [Google Scholar]
  56. Zeidler R., Eissner G., Meissner P., Uebel S., Tampe R., Lazis S., Hammerschmidt W.. 1997; Downregulation of TAP1 in B lymphocytes by cellular and Epstein–Barr virus-encoded interleukin-10. Blood90:2390–2397
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.18675-0
Loading
/content/journal/jgv/10.1099/vir.0.18675-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error